Trials / Completed
CompletedNCT06404593
Dynamic ctDNA Detection for Colorectal Cancer Liver Metastases
Dynamic ctDNA Detection for Guiding Adjuvant Therapy and Recurrence Monitoring After Curative Resection of Colorectal Cancer Liver Metastases: A Prospective Study
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 270 (actual)
- Sponsor
- Peking University Cancer Hospital & Institute · Academic / Other
- Sex
- All
- Age
- 20 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
Evaluating the value of dynamic monitoring of a colorectal cancer liver metastasis cohort underwent curative resection after receiving multipoint ctDNA detecting in predicting recurrence prognosis and guiding adjuvant chemotherapy treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Blood sampling | Evaluating the value of dynamic monitoring of a colorectal cancer liver metastasis cohort after receiving multipoint ctDNA detecting in predicting recurrence prognosis and guiding adjuvant chemotherapy treatment. |
Timeline
- Start date
- 2019-06-18
- Primary completion
- 2023-12-31
- Completion
- 2023-12-31
- First posted
- 2024-05-08
- Last updated
- 2024-05-08
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06404593. Inclusion in this directory is not an endorsement.